Volume 45 Issue 2
Feb.  2024
Turn off MathJax
Article Contents
Lei ZHU, Ruixue LI, Changlei BAO, Chenchen HUANG, Shuxin LIANG, Zhenlin ZHAO, Hong ZHU. Effect of MSC-exo,a New Cell Delivery Tool,on Gene Delivery and Proliferation of Pancreatic Cancer[J]. Journal of Kunming Medical University, 2024, 45(2): 39-48. doi: 10.12259/j.issn.2095-610X.S20240206
Citation: Lei ZHU, Ruixue LI, Changlei BAO, Chenchen HUANG, Shuxin LIANG, Zhenlin ZHAO, Hong ZHU. Effect of MSC-exo,a New Cell Delivery Tool,on Gene Delivery and Proliferation of Pancreatic Cancer[J]. Journal of Kunming Medical University, 2024, 45(2): 39-48. doi: 10.12259/j.issn.2095-610X.S20240206

Effect of MSC-exo,a New Cell Delivery Tool,on Gene Delivery and Proliferation of Pancreatic Cancer

doi: 10.12259/j.issn.2095-610X.S20240206
  • Received Date: 2023-11-01
    Available Online: 2024-02-26
  • Publish Date: 2024-02-25
  •   Objective  To observe the effect of a new cell delivery tool (MSC exo) on the proliferation of pancreatic cancer by transferring targeted genes.  Methods  Transmission Electron Microscope (TEM) and Nanoparticle Tracking Analysis(NTA) were used to identify human mesenchymal stem cell exosomes(MSC-exo) and transport miR-450a-5p into CFPAC-1, to explore the effect of miR-450a-5p targeting BZW2 on inhibiting the proliferation of pancreatic cancer cells.  Results  The expression of miR-450a-5p was low in pancreatic cancer tissue (P<0.05), and the expression of CD63 and TSG101 of MSC-exo-miR-450a-5p in CFPAC-1 cells was higher than that of MSC-exo by Western blot(P<0.05). CCK-8 and EdU results showed that MSC-exo-miR-450a-5p significantly inhibited the proliferation of CFPAC-1 cells (P<0.05). Cell scratch and Transwell experiments showed that MSC-exo-miR-450a-5p can inhibit the migration and invasion of CFPAC-1 cells (P<0.05). Through dual luciferase assay, it was confirmed that miR-450a-5p targets BZW2, and RT-qPCR and Western blotting showed a negative correlation (P<0.05) between miR-450a-5p and BZW2 expression. Overexpression of BZW2, CCK-8, EdU, cell scratch, and Transwell experiments confirmed that pc-BZW2 reversed the anti-cancer function of MSC-exo-miR-450a-5p on CFPAC-1. Western blot detected PCNA,Ki-67,MMP2,MMP9, and the results were consistent with the above experiments (P<0.05).  Conclusion  hMSC exo is a new delivery system, targeting BZW2 to transport miR-450a-5p to inhibit the biological malignancy of pancreatic cancer cells, which provides an important clue for the research of targeted treatment of pancreatic cancer.
  • loading
  • [1]
    Stoffel E M, Brand R E, Goggins M. Pancreatic cancer: Changing epidemiology and new approaches to risk assessment, early detection, and prevention[J]. Gastroenterology,2023,164(5):752-765. doi: 10.1053/j.gastro.2023.02.012
    [2]
    Yu J, Yang X, Wu H, et al. Clinical significance of color ultrasound, MRI, miR-21, and CA199 in the diagnosis of pancreatic cancer[J]. J Oncol,2021,2021:2380958.
    [3]
    Ji J, Cao C, Xu H: Minimally invasive intervention of obstructive jaundice in pancreatic cancer[J]. Integrative Pancreatic Intervention Therapy, 2021.
    [4]
    Hu ZI, O'Reilly EM. Therapeutic developments in pancreatic cancer[J]. Nat Rev Gastroenterol Hepatol,2024,21(1):7-24. doi: 10.1038/s41575-023-00840-w.Epub2023Oct5
    [5]
    Mihaljevic A L,Michalski C W,Friess H,et al. Molecular mechanism of pancreatic cancer—understanding proliferation, invasion, and metastasis[J]. Langenbeck's Archives of Surgery,2010,395(4):295-308.
    [6]
    Fu Y, Liu X, Chen Q, et al. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4[J]. Journal of Experimental & Clinical Cancer Research,2018,37(1):130.
    [7]
    Jiang M, Jike Y, Liu K, et al. Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1[J]. Mol Cancer,2023,22(1):113. doi: 10.1186/s12943-023-01804-z
    [8]
    Nakata K, Ohuchida K, Mizumoto K, et al. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis[J]. Surgery,2011,150(5):916-922. doi: 10.1016/j.surg.2011.06.017
    [9]
    Vogt M, Munding J, Gr ü ner M, et al. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas[J]. Virchows Archiv,2011,458(3):313-322. doi: 10.1007/s00428-010-1030-5
    [10]
    Hamada S, Satoh K, Fujibuchi W, et al. MiR-126 Acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9[J]. Molecular Cancer Research,2012,10(1):3-10. doi: 10.1158/1541-7786.MCR-11-0272
    [11]
    Zhang Y, Yu M, Dai M, et al. miR-450a-5p within rat adipose tissue exosome-like vesicles promotes adipogenic differentiation by targeting WISP2[J]. Journal of Cell Science,2017,130(6):1158-1168.
    [12]
    Chen H,Yao X,Di X,et al. MiR-450a-5p inhibits autophagy and enhances radiosensitivity by targeting dual-specificity phosphatase 10 in esophageal squamous cell carcinoma[J]. Cancer Lett,2020,28:483:114-126. doi: 10.1016/j.canlet.2020.01.037
    [13]
    Zhang Z W, Chen J J, Xia S H, et al. Long intergenic non-protein coding RNA 319 aggravates lung adenocarcinoma carcinogenesis by modulating miR-450b-5p/EZH2[J]. Gene,2018,15:650:60-67.
    [14]
    Zhao Y J, Zhang J, Wang Y C, et al. MiR-450a-5p inhibits gastric cancer cell proliferation, migration, and invasion and promotes apoptosis via targeting CREB1 and inhibiting AKT/GSK-3β signaling pathway[J]. Front Oncol,2021,29:11:633366. doi: 10.3389/fonc.2021.633366
    [15]
    Ribeiro M F, Zhu H, Millard R W, et al. Exosomes function in pro-and anti-angiogenesis[J]. Current Angiogenesis,2013,2(1):54. doi: 10.2174/22115528113020020001
    [16]
    Yeo R, Lai R C, Zhang B, et al. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery[J]. Adv Drug Deliv Rev,2013,65(3):336-341. doi: 10.1016/j.addr.2012.07.001
    [17]
    Gao L, Qiu F, Cao H, et al. Therapeutic delivery of microRNA-125a-5p oligonucleotides improves recovery from myocardial ischemia/reperfusion injury in mice and swine[J]. Theranostics,2023,13(2):685-703. doi: 10.7150/thno.73568
    [18]
    Ageta H, Tsuchida K. Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs[J]. Cellular and Molecular Life Sciences, 2019, 76(24): 4829-4848.
    [19]
    Gao W, Fei L, Liu L, et al. Endothelial colony-forming cell-derived exosomes restore blood-brain barrier continuity in mice subjected to traumatic brain injury[J]. Experimental Neurology,2018,307:99-108. doi: 10.1016/j.expneurol.2018.06.001
    [20]
    Silverman J M, Clos J, Horakova E, et al. Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells[J]. The Journal of Immunology,2010,185(9):5011-5022. doi: 10.4049/jimmunol.1000541
    [21]
    Paskeh M D A, Entezari M, Mirzaei S, et al. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling[J]. J Hematol Oncol,2022,15(1):83. doi: 10.1186/s13045-022-01305-4
    [22]
    Huang J, Yu M, Yin W, et al. Development of a novel RNAi therapy: Engineered miR-31 exosomes promoted the healing of diabetic wounds[J]. Bioactive Materials,2021,6(9):2841-2853. doi: 10.1016/j.bioactmat.2021.02.007
    [23]
    Kamerkar S, LeBleu V S, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer[J]. Nature,2017,546(7659):498-503. doi: 10.1038/nature22341
    [24]
    Choi H D, Chang M J. Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis[J]. PLoS One,2020,15(7):e0234818. doi: 10.1371/journal.pone.0234818
    [25]
    Chen J, Chen S, Zhuo L, et al. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer[J]. Cell Death Disease, 2020, 11: 173.
    [26]
    Sharma N S, Gupta V K, Dauer P, et al. O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability[J]. Theranostics, 2019, 9(12): 3410-3424.
    [27]
    Loughran G, Firth A E, Atkins J F, et al. Translational autoregulation of BZW1 and BZW2 expression by modulating the stringency of start codon selection[J]. PLoS ONE,2018,13(2):e0192648. doi: 10.1371/journal.pone.0192648
    [28]
    Antony P, Petro J B, Carlesso G, et al. B cell receptor directs the activation of NFAT and NF-kappaB via distinct molecular mechanisms[J]. Experimental Cell Research,2003,291(1):11-24. doi: 10.1016/S0014-4827(03)00338-0
    [29]
    Yu H, Lin L, Zhang Z, et al. Targeting NF-κB pathway for the therapy of diseases: Mechanism and clinical study[J]. Signal Transduct Target Ther,2020,5(1):209. doi: 10.1038/s41392-020-00312-6
    [30]
    Liu X, Hogg G D, Zuo C, et al. Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity[J]. Cancer Cell,2023,41(6):1073-1090.e12. doi: 10.1016/j.ccell.2023.04.018
    [31]
    Sun R Q, Qing Z L I, Yan H B, et al. Bzw2 Promotes Proliferation and Lactation of Mammary Epithelial Cell in Dairy Goat[J]. 农业科学学报:英文版,2012,11(11):8.
  • Relative Articles

    [1] Qingbin ZENG, Rong XU, Wenzhi DONG, Zhijian CHEN, Weiran LIAO, Kui LONG. Expression of Zinc Finger Transcription Factor Sall4 In Pancreatic Cancer and Its Impact on Cell Invasion and Migration. Journal of Kunming Medical University, 2025, 46(5): 1-7.
    [2] Runlin FENG, Zongqi DENG, Mengyao WU, Yunna WANG, Yu WANG, Guilan LIU. GJB4 Gene Expression in Relation to Clinical and Pathological Features of Pancreatic Cancer Patients. Journal of Kunming Medical University, 2024, 45(8): 1-9.
    [3] Sijia LIU, Yaying YANG, Chao PENG, Yamin LI. Application of Contrast-enhanced CT and MRI in Preoperative TNM Staging of Pancreatic Cancer. Journal of Kunming Medical University, 2023, 44(6): 107-112.  doi: 10.12259/j.issn.2095-610X.S20230628
    [4] Shijie CAO, Hongwei AN. Mechanism and Progress of MSC Derived Extracellular Vesicles in the Treatment of Ischemic Stroke. Journal of Kunming Medical University, 2023, 44(9): 155-160.  doi: 10.12259/j.issn.2095-610X.S20230913
    [5] Liang ZHANG, Baoquan WANG, Xifeng LEI, Xu WANG, Yang KE, Wei ZHANG. M2 Macrophage-derived Exosome miR-1246 Regulates the Growth and Invasion of Gastric Cancer Cells. Journal of Kunming Medical University, 2023, 44(7): 69-77.  doi: 10.12259/j.issn.2095-610X.S20230724
    [6] Jun GU, Zexi HE, Ting LUAN, Haifeng WANG, Jiansong WANG, Mingxia DING. Research Progress of Exosomes-derived Long Non-coding RNA in Bladder Cancer. Journal of Kunming Medical University, 2022, 43(1): 150-156.  doi: 10.12259/j.issn.2095-610X.S20220110
    [7] Tianhong ZHANG, Hongju YANG. Research Progress of Exosomal miRNA in Hepatocellular Carcinoma. Journal of Kunming Medical University, 2022, 43(2): 150-153.  doi: 10.12259/j.issn.2095-610X.S20220221
    [8] Xiao CAI, Xue-tao YI, Jing-qing YAO, Xin-yu DAI, Zhong-quan TANG, Ting OU, Xiao-min ZHAO, Yun-tao LI. The Regulation of Exosome Derived from Human Bone Marrow Mesenchymal Stem Cells on the Polarization of Glioma-associated Macrophages. Journal of Kunming Medical University, 2021, 42(1): 38-45.  doi: 10.12259/j.issn.2095-610X.S20210101
    [9] Jing-hui LI, Ming ZHU, Hai QU, Qiu-yu LI, Yu-juan WU, He-ying YANG, Yu-zhu WANG, Yan-ping LI. miR-490-3p Suppresses EMT of SW1990 Pancreatic Cancer Cells. Journal of Kunming Medical University, 2021, 42(3): 10-17.  doi: 10.12259/j.issn.2095-610X.S20210305
    [10] Li-ya MA, Nan-quan RAO, He-feng YANG. Research Progress of Mesenchymal Stem Cell Exosomes in Oral Tissue Regeneration. Journal of Kunming Medical University, 2021, 42(5): 147-153.  doi: 10.12259/j.issn.2095-610X.S20210527
    [11] Li Fei Fei , Hao Jin Gang . . Journal of Kunming Medical University, 2020, 41(04): 69-73.
    [12] Wei Han Xiao , Zhang Ai Jun , Li Qiang , Jin Pei Sheng . . Journal of Kunming Medical University, 2020, 41(09): 50-55.
    [13] Yin Shun Hui , Zhan Ye Ming , Jia Feng Mei , Ran Li Quan , Zhang Ming Zhu . . Journal of Kunming Medical University, 2019, 40(04): 23-30.
    [14] Jia Feng Mei , Yin Shun Hui , Ran Li Quan , Tian Ming Tong , Zhang Ming Zhu . . Journal of Kunming Medical University, 2019, 40(10): 15-20.
    [15] Yu Xiao Dong , Long Jiang . . Journal of Kunming Medical University, 2019, 40(09): 68-71.
    [16] Shen Hong , Wang Xiu Yun , Xu Hui Qiong , Liu Xia . Analysis of Clinicopathological Features of 274 Cases of Pancreatic Cancer and Risk Factors Affecting Prognosis. Journal of Kunming Medical University, 2019, 40(03): 97-101.
    [17] Yang Ke , Dan Zu Jian , Zhou Qiong Hua , Wang Jun Feng . Relationship between Soluble Cytokine Receptors, Matrix Metalloproteinases and Pancreatic Cancer. Journal of Kunming Medical University, 2017, 38(01): 99-102.
    [18] Lei Xue Fen . . Journal of Kunming Medical University,
    [19] . Inhibition of Canonical Wnt Signaling Pathway in Pancreatic Cancer by Interfering CXCR4 in Vitro. Journal of Kunming Medical University,
    [20] Yang Feng . . Journal of Kunming Medical University,
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(6)  / Tables(1)

    Article Metrics

    Article views (985) PDF downloads(10) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return